Cellectis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J.
CEOAndré Choulika
CEOAndré Choulika
Employees229
Employees229
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2000
Founded2000
Employees229
Employees229
CLLS Key Statistics
Market cap205.98M
Market cap205.98M
Price-Earnings ratio-4.14
Price-Earnings ratio-4.14
Dividend yield—
Dividend yield—
Average volume10.68K
Average volume10.68K
High today$2.79
High today$2.79
Low today$2.72
Low today$2.72
Open price$2.76
Open price$2.76
Volume4.20K
Volume4.20K
52 Week high$5.48
52 Week high$5.48
52 Week low$2.48
52 Week low$2.48
CLLS News
TipRanks 5h
Cellectis Updates Share Capital and Voting Rights as of July 31, 2026Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
TipRanks 6d
Cellectis Sets August 6 Date to Release Q2 2026 Results - TipRanks...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.